论文信息 - 392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study - 字舞流文

392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study

M. Friedlander | N. Colombo | G. Scambia | P. DiSilvestro | W. Bradley | E. Lowe | A. Oaknin | P. Rowe | K. Moore | A. González-Martín